INDIA 2.0: POWER OR PROMISE?

When Nirmala Sitharaman rose to present the Union Budget in February, she did not spend her opening minutes on poverty reduction targets or rural welfare schemes. She spoke about semiconductor fabrication, rare earth processing corridors, and the global biopharmaceutical market. The framing was deliberate, and worth taking seriously: this was a government signalling, with the specificity of line-item allocations rather than the vagueness of aspirational language, that it has a different ambition for what India makes, refines and sells to the world.

The long-horizon vision has a name — Viksit Bharat 2047, a developed India by the centenary of independence — but visions are cheap. What distinguishes this budget from its predecessors is the attempt to translate strategic intent into institutional architecture: dedicated missions with specific outlays, regulatory reforms with measurable targets, and a fiscal framework that accepts consolidation as the price of long-term credibility. Whether that architecture can actually be built, and whether it can be sustained across the electoral cycles that lie between now and 2031, is a separate question. But the seriousness of the attempt is harder to dismiss than it once was.

India has tried industrial policy before, with mixed results. The licence raj produced protected industries that never became competitive. The IT boom happened largely in spite of the state, not because of it. What is different now — and what this analysis attempts to assess — is whether the government has correctly identified the structural preconditions for manufacturing depth, and whether it has the administrative capacity to create them. The budget suggests it understands the question. Understanding a question and answering it are not the same thing.

The numbers in the budget are, by the standards of large emerging economies, reasonably disciplined. Capital expenditure rises to ₹12.2 lakh crore, an increase of around 9% on the previous year, continuing a decade-long commitment to infrastructure as the engine of growth. The fiscal deficit narrows to 4.3% of GDP. The government has, for the first time, shifted its medium-term framing from annual deficit reduction to an overall debt target — 50% of GDP, give or take a percentage point, by 2031. Taken together, these figures say: we are spending seriously on long-term assets, and we are not losing fiscal discipline while doing so.

That combination is harder to maintain than it sounds. Most governments facing the pressures India faces — a general election cycle every five years, a population that still contains hundreds of millions of people without reliable access to healthcare, education or formal employment — find reasons to spend on visible, short-term consumption rather than patient capital formation. The fact that this government has not, at least in the headline numbers, is politically significant. The problem is what lies beneath the headline. India's gross tax-to-GDP ratio remains stuck at around 11–12%, one of the lowest among large economies at India's income level. That structural constraint does not appear in the budget speech. It determines everything that does. A state that cannot collect more than 12 rupees in tax from every 100 rupees of national income cannot simultaneously build world-class semiconductor infrastructure, fund a universal health system, modernise its universities, and maintain a ₹7.84 lakh crore defence budget — at least not without making trade-offs it has yet to acknowledge publicly.

For now, the trade-offs are being managed through the dominance of public over private investment. The government spends; the private sector watches. Gross Fixed Capital Formation by private firms has been running well below its pre-2008 peak relative to GDP, and no budget measure has yet reversed that reluctance. India 2.0 is, in this sense, a government-led project in search of private-sector validation. It will remain one until industry decides the policy environment is predictable enough to justify the kind of decade-long capital commitments that semiconductor fabs or biologics manufacturing facilities require.

The budget's strategic ambition is concentrated in seven sectors that the government has designated as the primary sites of manufacturing depth and indigenous technology creation. Read together, they constitute a particular theory of where global industrial value is migrating — toward materials critical to the energy transition, toward biologics that patent cliffs are opening to competition, toward electronics components that the US-China rupture has made strategically sensitive. India is placing bets on each of these migrations simultaneously, which is either visionary or overextended, depending on whether the institutions required to execute them can be built in time.

The three sectors at the strategic core reveal the ambition most clearly. Semiconductor Mission 2.0 has been recalibrated with an ₹8,000 crore FY27 outlay directed not at chip assembly — where India already has some presence — but at equipment manufacturing, materials development, and what the government calls "full-stack Indian IP": the kind of design capability that turns a country from a node in someone else's supply chain into an originator of its own. The gap between those two positions is wide. Taiwan's TSMC did not emerge from a government mission statement; it emerged from four decades of accumulated engineering knowledge, precision water management, stable power, and a supplier base dense enough that a fab manager could source a critical chemical within hours. India is starting most of that from a much lower base, and the ₹8,000 crore outlay, while not trivial, is a fraction of what a single advanced fabrication facility costs to build and certify.

Rare Earth Corridors are a more achievable near-term bet. India sits on 13.15 million tonnes of monazite — beach sand deposits concentrated along the coastlines of Odisha, Kerala, Andhra Pradesh and Tamil Nadu — which contain roughly 7.23 million tonnes of rare earth oxides. The elements that matter most are neodymium, praseodymium, dysprosium and terbium: the backbone of the permanent magnets used in every EV motor, wind turbine and missile guidance system. Currently, India imports 60–80% of its requirements for these magnets from China. The corridor model — integrating extraction, processing, refining and manufacturing in geographically linked hubs — is designed to change that. It is, in principle, a sensible use of a resource advantage India genuinely has. Whether the integrated model actually integrates, or whether it fragments into familiar patterns of mining without downstream processing, will depend on state-level administrative capability and private-sector participation in the manufacturing end of the chain. Defence allocation at ₹7.84 lakh crore, with capital outlay rising sharply, sits alongside these industrial missions as a companion ambition. India's defence sector is increasingly oriented toward domestic production — which serves both the security objective and the manufacturing one. The trade-off it creates, against health, education and urban infrastructure, is real and so far unresolved.

India's pharmaceutical industry is one of the genuine success stories of its post-liberalisation economy. The country supplies roughly 20% of global generic medicine volumes and is the source of a significant portion of the antiretrovirals, antimalarials and childhood vaccines that keep the global health system functioning at anything approaching affordable cost. That legacy is real. It is also, in terms of economic value capture, reaching its ceiling. Generics are a scale business that compress margins over time as more competitors enter markets. The global biopharmaceutical industry — monoclonal antibodies that treat cancer and autoimmune disease, mRNA platforms that can be reconfigured for new pathogens, GLP-1 receptor agonists for obesity and diabetes, biosimilars as the next wave of generics — is where pharmaceutical value has migrated, and India is structurally absent from it. Indian firms make almost none of these products, run almost no Phase I or Phase II clinical trials of global significance, and have almost no regulatory scientists capable of navigating the FDA or EMA approval processes that govern access to the markets where this value is captured.

The ₹10,000 crore Biopharma SHAKTI mission is a structured attempt to change that over five years. Its logic is worth understanding carefully, because the architecture of the intervention is more sophisticated than a simple funding announcement. The government is not merely paying for buildings. It is trying to construct three interdependent capabilities simultaneously: the physical infrastructure of clinical research, meaning 1,000 accredited trial sites distributed across India's hospital network; the human infrastructure of regulatory science, through upgrades to seven existing NIPERs and the establishment of three new ones, with curricula redesigned to produce clinical research coordinators, regulatory toxicologists and bioprocessing specialists rather than the formulation chemists the current system generates; and the institutional infrastructure of regulatory credibility, through a strengthened scientific review cadre within the CDSCO and alignment with the FDA and EMA standards that determine whether Indian clinical data can be used to support drug approvals globally. The 5% global biopharmaceutical market share target by 2031 depends on all three of these tracks progressing together. If the sites are built but the regulatory scientists are not trained, the data produced will not be trusted. If the scientists are trained but the CDSCO remains slow, approval timelines will remain uncompetitive. These are not sequenced problems. They are simultaneous ones, which is a significant test of a state that has historically been better at doing one big thing at a time.

Ask any foreign executive who has tried to do business in India for more than a decade what their single biggest concern is, and most will not mention corruption or infrastructure. They will mention tax. The Indian tax system has, for years, operated with a degree of retrospective aggression and interpretive unpredictability that has earned it the nickname "tax terrorism" among the investor community — a phrase that has appeared in enough boardroom conversations that the government is clearly aware of it. The 2026–27 budget is, among other things, an attempt to retire that reputation. Whether it succeeds will matter more to India's manufacturing ambitions than any individual sector mission.

The measures announced are substantive. The new Income-tax Act, effective April 2026, is designed to simplify compliance and eliminate the litigation-generating ambiguity that has historically made Indian tax assessments hard to predict. The Minimum Alternate Tax has been reduced to 14% and designated as a final tax, removing the long-standing uncertainty about whether future credits would be clawed back. Foreign manufacturers incorporating in India between 2026 and 2029 are offered a 15% concessional corporate tax rate, provided they meet investment and employment thresholds. Global cloud providers routing services through Indian data centres receive a tax holiday extending to 2047 — a 21-year guarantee of fiscal stability for a sector the government wants to anchor in Indian infrastructure. Decriminalisation of 288 minor procedural offences, integration of 32 central and 32 state-level approval processes through a single digital window, and halving of the pre-deposit required to contest a tax assessment all point in the same direction: a state attempting to signal that it has moved from adversary to coordinator.

The honest caveat is that India has announced regulatory simplification before. The World Bank's Ease of Doing Business ranking improved dramatically between 2014 and 2020 on the strength of similar announcements, and then stalled. The reforms that appear in budget speeches are the easy part. What happens when a mid-level tax officer in a state that has not embraced the Single Window interprets an ambiguous provision is the hard part, and no Finance Minister can legislate that away from New Delhi. The 350+ reforms in this budget create the legal architecture for predictability. Creating the administrative culture to match it is a different, longer-horizon project.

There are structural constraints on India's manufacturing ambitions that no budget speech can resolve, and that will determine the ceiling on India 2.0 more than any specific mission announcement. They are worth naming plainly, because the gap between what the budget promises and what these constraints permit is where optimistic projections tend to collapse.

The first is power. Any manufacturer who has tried to run a precision production line in India will tell you the same thing: the electricity is unreliable. Not catastrophically — there are no rolling blackouts in the industrial zones the government is trying to develop — but intermittently and unpredictably, in ways that matter enormously for advanced manufacturing. A semiconductor wafer fabrication line that experiences a voltage fluctuation loses the batch. A biologics cold chain that loses power for four hours loses the product. India's renewable energy expansion is genuine and impressive; installed solar capacity has grown at a rate that has surprised even optimistic forecasters. But the grid management, storage infrastructure and transmission capacity required to deliver stable, high-quality power to the industrial users that semiconductor fabs and biotech facilities represent has not kept pace with generation capacity. The government knows this. The budget does not yet contain a credible answer to it at the scale India 2.0 requires.

The second is water. Semiconductor fabrication uses enormous quantities of ultra-pure water — a single fab can consume tens of millions of litres per day. Advanced biologics manufacturing is similarly water-intensive. India is among the most water-stressed large economies in the world, and the regions where it is planning its most ambitious industrial clusters are not its most water-secure. This is not an insurmountable problem; it is a planning and investment problem. But it requires explicit treatment in industrial site selection, water recycling infrastructure, and regulation that India's current industrial policy documents do not consistently provide.

The third, and in some ways the most fundamental, is employment. India adds roughly 10–12 million people to its working-age population every year. Its economy, even growing at 7%, is not creating formal jobs at anything close to that rate. Employment elasticity — the proportion of GDP growth that translates into employment growth — is near 0.2, meaning that for every additional percentage point of economic growth, formal employment grows by roughly a fifth of a percentage point. The industries at the centre of India 2.0 — semiconductor fabrication, biologics manufacturing, advanced capital goods — are capital-intensive industries that employ relatively few people per rupee of output. They can generate export earnings, tax revenue and strategic capability. They cannot absorb the hundreds of millions of young Indians entering the labour market over the next two decades. That absorption has to come from textiles, food processing, construction, retail and the services ecosystem around heavy industry — the sectors that the budget addresses less prominently, and that receive less rhetorical attention than rare earth corridors. The demographic dividend that India's boosters invoke is real. It becomes a demographic liability if growth concentrates in sectors that require specialist skills that most of the workforce does not and cannot quickly acquire.

Every serious analysis of India's manufacturing ambitions eventually arrives at the same uncomfortable comparison. China's industrial base was built over four decades of sustained, coordinated state investment in supplier ecosystems, technical education, infrastructure and export-oriented policy. The result is not simply a large economy that manufactures things. It is a system in which a company that needs a particular grade of steel, a specific chemical compound, or a precision-machined component can typically find a domestic supplier within a few hours' drive of its factory. That density — the clustering of knowledge, capability and supply — is what makes Chinese manufacturing so difficult to replicate quickly. It is not labour cost, which has been rising for years. It is the accumulated advantage of being the place where industrial problems get solved at scale.

India's structural position is different. Its industrial clusters are real but thin: good in patches, absent in others, and rarely deep enough to support the full supply chain of an advanced manufacturing sector. A company building a semiconductor fab in India today cannot source most of its inputs domestically. It imports the chemicals, the specialised gases, the precision equipment, the photomasks. It trains its engineers partly abroad or from a very shallow domestic pool. The ecosystem that would make it competitive against an equivalent Taiwanese or South Korean facility does not yet exist, and cannot be created by a single budget cycle or a single government mission.

This is not an argument against trying. The China+1 diversification impulse among global manufacturers and governments is genuine, and India is one of very few countries with the scale to absorb significant manufacturing relocation. Apple's expansion of iPhone assembly in Tamil Nadu and Karnataka demonstrates that large, sophisticated producers are willing to invest in India when the incentive structure and logistics infrastructure meet minimum thresholds. The question is whether assembly — which is what most of what is happening today amounts to — transitions into the deeper forms of value creation that India 2.0 is designed to produce. Assembly requires reliable logistics, cheap labour and stable policy. Advanced manufacturing requires all of that plus dense supplier networks, specialised human capital, reliable utilities and regulatory predictability sustained over decades rather than election cycles. India has the first set of conditions in improving but imperfect form. It is working on the second. The gap between the two is where India 2.0 either succeeds or stalls.

India's industrial strategy is being built into a global economy that is neither stable nor cooperative. Two external risks deserve attention, because they interact in ways that could compress the window India is trying to exploit.

The first is demand. The high-value export markets that India 2.0 is targeting — advanced biologics, semiconductor components, specialty chemicals, high-end electronics — are concentrated in the United States and the European Union. Both economies are running elevated debt levels, tightening monetary conditions, and facing political pressures that favour domestic industrial policy over open import regimes. If either enters a serious slowdown over the 2026–2031 period, the return on India's corridor and mission investments will be delayed, which will test the government's willingness to sustain capital allocation in the absence of near-term revenue. Sustained public investment is much easier to maintain when growth is generating fiscal headroom. India's current fiscal trajectory assumes it will be.

The second is competitive response. The China+1 thesis has been in circulation for several years, and India is not the only candidate. Vietnam, Indonesia, Mexico and Poland have all captured manufacturing relocation in specific sectors over the same period. More importantly, China itself is not standing still. Chinese firms are moving up the value chain in precisely the sectors India is targeting — electric vehicle components, pharmaceutical ingredients, rare earth processing — and doing so with state backing and capital costs that Indian competitors cannot easily match. The window for India to establish itself as an indispensable node in global supply chains before Chinese firms consolidate their positions at higher value-add levels is real. It is probably a decade, not two. That timetable does not forgive administrative delays or policy inconsistency.

India's government has a reasonable record of doing large, visible things when it decides to. The national highway programme has been building roads at a pace — over 30 kilometres per day at its peak — that would have seemed implausible fifteen years ago. The Unified Payments Interface has become, in a decade, one of the most widely used digital payment systems in the world, processing more monthly transactions than Visa and Mastercard combined in India. The solar energy programme has deployed capacity faster than almost any comparable economy at a similar income level. These are genuine achievements. They demonstrate that the Indian state, when it commits to a specific, measurable, politically-supported objective, can execute at scale.

The difficulty with India 2.0 is that it requires this kind of execution in five or six domains simultaneously, each of which involves longer timelines, more complex institutional co-ordination, and less visible short-term results than highway construction or digital payments. A semiconductor ecosystem takes a decade to build, not a term of government. A biopharmaceutical industry capable of running FDA-credible Phase I trials requires regulatory scientists who take years to train, and a CDSCO that has been institutionally transformed rather than merely instructed to move faster. Rare earth corridors that actually integrate mining with manufacturing require private-sector partners willing to invest in the processing and magnet-production end, which they will only do if they believe the policy framework will remain stable long enough to earn a return. These are not engineering problems. They are institutional ones, and India's institutions — its bureaucracy, its regulatory bodies, its state governments — vary enormously in their capacity and consistency.

There is a test that cuts across all of the others and that receives almost no attention in the budget documents: carbon. India's manufacturing expansion is concentrated in exactly the industries — steel, aluminium, cement, chemicals, fertilisers — that the European Union's Carbon Border Adjustment Mechanism is designed to price. CBAM is not a future risk. It is a current one. The mechanism entered its transitional phase in 2023 and reaches full implementation by 2026, meaning that Indian exporters of covered goods to the EU will be paying carbon costs within the current budget cycle. Industrial policy that builds export capacity in carbon-intensive sectors without integrating emissions management into the investment thesis is building toward a trade disadvantage that will compound year on year. The government's budget documents do not treat this as a priority. They should, because the EU is not a marginal market for the industries India is trying to develop — it is one of the two largest end-markets for the products of India 2.0.

The honest assessment is this: India 2.0 is the most coherent and seriously resourced attempt at industrial strategy that India has undertaken since liberalisation. Its logic is sound. Its targets are specific enough to be evaluated. Its fiscal framework is disciplined enough to be credible. None of that guarantees it will work. The outcome will be decided not in the budget speech but in the ten thousand administrative decisions — about power grid investment, water allocation, customs clearance times, CDSCO staffing, state-level land acquisition — that the budget sets in motion but cannot control. That is where India's institutional capacity will be tested. And that is where, historically, promising Indian policy has most often fallen short of its ambition.